Lantheus Holdings Inc (NASDAQ:LNTH)

13.54
Delayed Data
As of Aug 12
 -0.15 / -1.10%
Today’s Change
8.67
Today|||52-Week Range
27.12
-33.98%
Year-to-Date
FDA OKs Lantheus ultrasound imaging agent
Aug 12 / Seeking Alpha - Paid Partner Content
Lantheus EPS beats by $0.02, beats on revenue
Jul 30 / Seeking Alpha - Paid Partner Content
Lantheus Holdings, Inc.'s (LNTH) CEO Mary Anne Heino on Q2 2020 Results - Earnings Call Transcript
Jul 31 / Seeking Alpha - Paid Partner Content
Notable earnings before Thursday's open
Jul 29 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close13.68
Today’s open13.79
Day’s range13.43 - 13.86
Volume488,575
Average volume (3 months)628,572
Market cap$841.8M
Data as of 3:59pm ET, 08/12/2020

Growth & Valuation

Earnings growth (last year)-23.36%
Earnings growth (this year)-63.53%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+1.15%
P/E ratio46.7
Price/Sales2.37
Price/Book4.55

Competitors

 Today’s
change
Today’s
% change
MYGNMyriad Genetics Inc+0.64+5.15%
AXDXAccelerate Diagnosti...-0.16-1.08%
VIVOMeridian Bioscience ...-0.02-0.11%
TRILTrillium Therapeutic...+0.01+0.12%
Data as of 3:59pm ET, 08/12/2020

Financials

Next reporting dateNovember 3, 2020
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$347.3M
Annual profit (last year)$31.7M
Net profit margin9.12%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
North Billerica, Massachusetts

Forecasts